All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF328 | Anti-Human EGFR806 (XW-328) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-328 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF338 | Anti-Human EGFR806 (XW-338) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-338 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-1122-YF328 | Anti-EGFR806 KIR CAR (scFv-KIR2DS2-DAP12, XW-328), pCDCAR1 | Human | XW-328 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF338 | Anti-EGFR806 KIR CAR (scFv-KIR2DS2-DAP12, XW-338), pCDCAR1 | Human | XW-338 | Human | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF1248 | Anti-EGFR806 TCR-ABR (scFv-TCRα, XW-328) CAR Plasmid, pCDCAR1 | Human | XW-328 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1258 | Anti-EGFR806 TCR-ABR (scFv-TCRα, XW-338) CAR Plasmid, pCDCAR1 | Human | XW-338 | Human | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF2168 | Anti-EGFR806 TCR-ABR (scFv-TCRβ, XW-328) CAR Plasmid, pCDCAR1 | Human | XW-328 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2178 | Anti-EGFR806 TCR-ABR (scFv-TCRβ, XW-338) CAR Plasmid, pCDCAR1 | Human | XW-338 | Human | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3088 | Anti-EGFR806 TCR-ABR (scFv-CD3γ, XW-328) CAR Plasmid, pCDCAR1 | Human | XW-328 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3098 | Anti-EGFR806 TCR-ABR (scFv-CD3γ, XW-338) CAR Plasmid, pCDCAR1 | Human | XW-338 | Human | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF4008 | Anti-EGFR806 TCR-ABR (scFv-CD3δ, XW-328) CAR Plasmid, pCDCAR1 | Human | XW-328 | Mouse | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4018 | Anti-EGFR806 TCR-ABR (scFv-CD3δ, XW-338) CAR Plasmid, pCDCAR1 | Human | XW-338 | Human | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4928 | Anti-EGFR806 TCR-ABR (scFv-CD3ε, XW-328) CAR Plasmid, pCDCAR1 | Human | XW-328 | Mouse | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF4938 | Anti-EGFR806 TCR-ABR (scFv-CD3ε, XW-338) CAR Plasmid, pCDCAR1 | Human | XW-338 | Human | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5848 | Anti-EGFR806 (XW-328) h(CD28-CD3ζ) CAR, pAAV | Human | XW-328 | Mouse | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF5858 | Anti-EGFR806 (XW-338) h(CD28-CD3ζ) CAR, pAAV | Human | XW-338 | Human | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6768 | Anti-EGFR806 (XW-328) h(41BB-CD3ζ) CAR, pAAV | Human | XW-328 | Mouse | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6778 | Anti-EGFR806 (XW-338) h(41BB-CD3ζ) CAR, pAAV | Human | XW-338 | Human | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7688 | Anti-EGFR806 (XW-328) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-328 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7698 | Anti-EGFR806 (XW-338) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-338 | Human | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION